German Diabetes Center
Düsseldorf, North Rhine-Westphalia, 40225, Germany
Location status: Recruiting
NCT Number: NCT06150690
The study investigates the mechanisms underlying the pathogenesis of diabetes by examining structural and functional properties of islets of Langerhans in pancreas specimen from patients undergoing (partial) pancreatectomy.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Düsseldorf, North Rhine-Westphalia, 40225, Germany
Location status: Recruiting
The study aims at elucidating the mechanisms underlying the pathogenesis of diabetes. In particular, the study focusses on detailed analyses of morphological and functional properties of pancreatic islets/insulin-producing beta cells in order to identify diabetes-associated alterations on cellular and molecular levels. To directly address the role of the endocrine (and exocrine) pancreas in the complex process of diabetes development, the examinations are performed in samples of human pancreatic tissue. To this end, biopsy specimen of pancreas and visceral adipose tissue are collected from patients with or without diabetes who undergo (partial) pancreatectomy. The samples are analysed for morphological alterations (e.g. size and distribution of pancreatic islets and beta cells, size of adipocytes) and functional changes (e.g. gene expression patterns as assessed from beta-cell derived RNA). In addition, patient characteristics such as age and disease duration are documented and clinical data including fasting concentrations of blood glucose, insulin and free fatty acids are collected. Specific diabetes-associated alterations of pancreatic islet / beta cells are assessed by associating variables of glucose- and lipid-homeostasis with parameters of beta cell function. The expected outcomes of the study will contribute to improve our knowledge of the so far largely unknown molecular and cellular mechanisms involved in the pathogenesis of diabetes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
ability to give informed consent
Exclusion criteria
denial of informed consent
The participants did not receive any study-specific intervention
Time frame: 1 year
Proportion of glycated HbA1c (in %) as determined from pre-operative serum samples
Time frame: 1 year
Size of pancreatic islets of Langerhans (in square micrometers) as determined by microscopic/morphometric analyses of appropriately stained thin sections of pancreatic tissue samples
Contact information is provided by the study sponsor or research team.
German Diabetes Center
Other
Study on the Function of Insulin-producing Beta Cells in the Human Pancreas
Acronym: PRECISE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04055428
Cardiovascular Diseases, Diabetes Mellitus
Birmingham, Alabama, United States
View Trial DetailsNCT06337708
Behavior, Cardiovascular Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT00001987
Diabetes Mellitus, Endocrine System Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT07006480
Diabetes Mellitus, Endocrine System Diseases
Jacksonville, Florida, United States
View Trial Details